Rasha Aboelhassan: From Endocrine Therapy to Precision Molecular-targeted Treatments
Rasha Aboelhassan/LinkedIn

Rasha Aboelhassan: From Endocrine Therapy to Precision Molecular-targeted Treatments

Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:

“From endocrine therapy and chemotherapy to precision molecular-targeted treatments, experts are coming together to shape the future of prostate cancer care in Egypt.

A collaborative, patient-centered approach toward building practical treatment algorithms tailored to our patients’ needs thanks for your efforts all my mentors and experts for yesterday meeting.”

Rasha Aboelhassan

Other articles about Endocrine Therapy on OncoDaily.